###begin article-title 0
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
Molecular Etiology of Hearing Impairment in Inner Mongolia: mutations in SLC26A4 gene and relevant phenotype analysis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 213 221 213 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
The molecular etiology of hearing impairment in Chinese has not been thoroughly investigated. Study of GJB2 gene revealed that 30.4% of the patients with hearing loss in Inner Mongolia carried GJB2 mutations. The SLC26A4 gene mutations and relevant phenotype are analyzed in this study.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 316 324 316 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
###xml 198 205 <span type="species:ncbi:9606">patient</span>
###xml 261 268 <span type="species:ncbi:9606">patient</span>
###xml 302 310 <span type="species:ncbi:9606">patients</span>
One hundred and thirty-five deaf patients were included. The coding exons of SLC26A4 gene were sequence analyzed in 111 patients, not including 22 patients carrying bi-allelic GJB2 mutations or one patient carrying a known GJB2 dominant mutation as well as one patient with mtDNA 1555A>G mutation. All patients with SLC26A4 mutations or variants were subjected to high resolution temporal bone CT scan and those with confirmed enlarged vestibular aqueduct and/or other inner ear malformation were then given further ultrasound scan of thyroid and thyroid hormone assays.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 115 123 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 248 256 248 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 412 420 412 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 11 19 <span type="species:ncbi:9606">patients</span>
###xml 90 98 <span type="species:ncbi:9606">patients</span>
###xml 213 221 <span type="species:ncbi:9606">patients</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
Twenty-six patients (19.26%, 26/135) were found carrying SLC26A4 mutation. Among them, 17 patients with bi-allelic SLC26A4 mutations were all confirmed to have EVA or other inner ear malformation by CT scan. Nine patients were heterozygous for one SLC26A4 mutation, including 3 confirmed to be EVA or EVA and Mondini dysplasia by CT scan. The most common mutation, IVS7-2A>G, accounted for 58.14% (25/43) of all SLC26A4 mutant alleles. The shape and function of thyroid were confirmed to be normal by thyroid ultrasound scan and thyroid hormone assays in 19 of the 20 patients with EVA or other inner ear malformation except one who had cystoid change in the right side of thyroid. No Pendred syndrome was diagnosed.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 149 157 149 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 331 339 331 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 423 431 <span type="species:ncbi:9606">patients</span>
In Inner Mongolia, China, mutations in SLC26A4 gene account for about 12.6% (17/135) of the patients with hearing loss. Together with GJB2 (23/135), SLC26A4 are the two most commonly mutated genes causing deafness in this region. Pendred syndrome is not detected in this deaf population. We established a new strategy that detects SLC26A4 mutations prior to the temporal bone CT scan to find EVA and inner ear malformation patients. This model has a unique advantage in epidemiologic study of large deaf population.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 698 699 698 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 809 813 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 34 42 <span type="species:ncbi:9606">children</span>
###xml 96 103 <span type="species:ncbi:9606">infants</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
###xml 279 287 <span type="species:ncbi:9606">children</span>
###xml 651 659 <span type="species:ncbi:9606">patients</span>
###xml 728 736 <span type="species:ncbi:9606">patients</span>
Every year in China, about 30,000 children, compared to 840 in UK and one of every one thousand infants in US, are born with congenital hearing impairment[1-3]. Hearing impairment is the most common neurosensory disorder in human that has an incidence of approximately 1 in 1000 children worldwide[4]. About 50-60% of these cases have a genetic cause. The most common molecular defects for nonsyndromic autosomal recessive deafness lie on Connexin 26, a gap junction protein encoded by the GJB2[5-12]. More than 150 mutations, polymorphisms and unclassified variants have been described in GJB2 to account for about 8-40% of molecular etiology of the patients with nonsyndromic hearing impairment [3]. However, about 80% of the patients with nonsyndromic hereditary deafness in China do not have mutations in GJB2[13].
###end p 11
###begin p 12
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 205 213 205 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 991 999 991 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1131 1139 1131 1139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 1273 1275 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1276 1278 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1351 1358 1351 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 1359 1361 1359 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1362 1364 1362 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1365 1367 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1368 1370 1368 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1439 1441 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1442 1444 1442 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1445 1447 1445 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1448 1450 1448 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1451 1453 1451 1453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1454 1456 1454 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1555 1563 1555 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 1702 1704 1702 1704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1705 1707 1705 1707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1859 1861 1859 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1968 1976 1968 1976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 2018 2020 2018 2020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 2021 2023 2021 2023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 2274 2282 2274 2282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 2298 2300 2298 2300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 2500 2502 2500 2502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2605 2607 2605 2607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 2802 2804 2802 2804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2805 2807 2805 2807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 2908 2910 2908 2910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 382 390 <span type="species:ncbi:9606">patients</span>
###xml 1070 1078 <span type="species:ncbi:9606">patients</span>
###xml 1488 1496 <span type="species:ncbi:9606">patients</span>
###xml 1617 1625 <span type="species:ncbi:9606">patients</span>
###xml 1771 1779 <span type="species:ncbi:9606">patients</span>
###xml 1891 1899 <span type="species:ncbi:9606">patients</span>
###xml 1919 1927 <span type="species:ncbi:9606">patients</span>
###xml 2054 2062 <span type="species:ncbi:9606">patients</span>
###xml 2251 2259 <span type="species:ncbi:9606">patients</span>
###xml 2778 2786 <span type="species:ncbi:9606">patients</span>
###xml 2977 2985 <span type="species:ncbi:9606">patients</span>
Pendred syndrome (PS) is the most common form of syndromic deafness that accounts for about 10% of hereditary hearing impairment[14]. It is an autosomal recessive disorder caused by biallelic mutations in SLC26A4 resulting in hearing loss, enlargement of the vestibular aqueduct (EVA) and iodine organification defect in the thyroid gland[15]. EVA is always detected in the ears of patients with PS by computed tomography (CT) and magnetic resonance imaging (MRI)[16]. EVA is the most common form of the inner ear malformation associated with prelingual or postlingual sensorineural hearing loss and is an important feature of PS[17,18]. EVA may occur alone or in combination with an incomplete partition of the apical turn of the cochlea as part of Mondini deformity. PS is differentiated from nonsyndromic hearing loss with EVA by the presence of goiter, which usually develops later at around the time of puberty. Since environmental and other genetic factors may modulate the effects of SLC26A4 mutations on the development of goiter, the expression of goiter in PS patients is variable and may have incomplete penetrance[19]. SLC26A4 encodes an anion (chloride/iodide) transporter transmembrane protein, pendrin, which is expressed in the thyroid, kidney, and cochlea[20,21]. DNA sequence analysis identified more than 100 different mutations in SLC26A4[10,15,22-27]. The mutation spectrum varies widely among different ethnic groups[10,15,19,23,26-30]. Park and Pryor observed that patients with PS were always associated with two mutant alleles in SLC26A4 consistent with autosomal recessive disorder, whereas patients with nonsyndromic hearing loss and EVA might have one or zero mutant allele[15,19]. In Caucasian nonsyndromic EVA cohort, about one third of the patients had two mutant alleles, one third had one mutant allele and one third had zero[19]. In Japanese and Korean EVA patients, the proportion of patients having two identified mutant alleles in SLC26A4 is much higher, 57% and 81%, respectively[24,29]. Whereas in China, 97.9% EVA patients in simplex families were detected with either biallelic or monoallelic mutations, of which 88.4% were carrying biallelic variants and 9.5% with monoallelic mutation. Only 2.1% Chinese EVA patients had no mutant SLC26A4 allele detected[27]. In addition, the prevalent mutations in different ethnic groups are very different. Campbell et al. reported T416P and IVS8+1G>A as the two most frequent mutations in northern European population [22], while Blons et al. showed a completely different mutation spectrum that was extremely heterogeneous[23]. In Japanese, H723R accounted for 53% of the mutant alleles, and in Korean, the H723R and the IVS7-2A>G mutation was the most prevalent mutation accounting for 45.5% of patients with PS or EVA[19,29]. In China, IVS7-2A>G mutation was the most common form accounting for 57.63% of the mutant alleles[27]. All of the above studies focused on the EVA or Pendred syndrome patients.
###end p 12
###begin p 13
###xml 224 232 224 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 91 99 <span type="species:ncbi:9606">patients</span>
###xml 179 187 <span type="species:ncbi:9606">patients</span>
###xml 272 280 <span type="species:ncbi:9606">patients</span>
In order to investigate the ratio of EVA or Pendred syndrome in Chinese hearing impairment patients and provide effective genetic testing and accurate counseling for hearing loss patients and families in China, we performed SLC26A4 sequence analysis in hearing impairment patients in Chifeng City from Inner Mongolia and then made a genotype-phenotype correlation analysis.
###end p 13
###begin title 14
Materials and methods
###end title 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and DNA samples
###end title 15
###begin p 16
###xml 1238 1246 1236 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
###xml 294 302 <span type="species:ncbi:9606">patients</span>
###xml 554 562 <span type="species:ncbi:9606">patients</span>
###xml 662 670 <span type="species:ncbi:9606">patients</span>
###xml 712 715 <span type="species:ncbi:9606">Man</span>
###xml 1037 1044 <span type="species:ncbi:9606">patient</span>
A total of 135 deaf students from unrelated families of Chifeng Special Education School in Inner Mongolia, China, were included in this study. Among them, 73 patients suffered pre-lingual hearing impairment and 28 patients suffered post-lingual hearing impairment. The onset of deafness of 34 patients was unclear. Chifeng City Special Education School is the only deaf mute school in this area. All students with moderate to profound hearing loss from Chifeng city and within 500 km diameter of its neighboring area come to this school. This cohort of patients consists of 85 male and 50 female from 3 to 20 years old with the average age of 13.2 +/- 3.6. The patients include 94 of Han, 31 of Mongolian, 7 of Man, and 3 of Hui races. This study was performed according to a protocol approved by the ethnicity committee of the Chinese PLA General Hospital. Informed consent was obtained from all parents prior to blood sampling. Parents were interviewed for age of onset, family history, mother's health condition during pregnancy and patient's clinical history including infection, possible head or brain injury and the usage of aminoglycoside antibiotics. In addition, 50 (race matched) controls with normal hearing were screened for SLC26A4 mutations by DHPLC followed by sequencing analysis. DNA was extracted from peripheral blood leukocytes using commercially available DNA extraction kit (Watson Biotechnologies Inc, Shanghai, China).
###end p 16
###begin title 17
Mutational analysis
###end title 17
###begin p 18
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2</italic>
###xml 45 54 45 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">12S rRNA </italic>
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 386 391 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 461 467 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mtDNA </italic>
###xml 526 534 526 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 558 566 558 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 368 376 <span type="species:ncbi:9606">Patients</span>
###xml 587 595 <span type="species:ncbi:9606">patients</span>
DNA sequence analysis of GJB2, mitochondrial 12S rRNA and SLC26A4 were performed by PCR amplification of the coding exons plus approximated 50-100 bp of the flanking intron regions followed by Big Dye sequencing and analysis using ABI 3100 DNA sequencing machine (ABI, Foster City, USA.) and ABI 3100 Analysis Software v.3.7 NT according to manufacturer's procedures. Patients with two GJB2 mutant alleles (22 cases) or one dominant mutant allele (one case) or mtDNA 1555 A>G mutation (one case) were not further analyzed for SLC26A4 mutations. The exons of SLC26A4 of the remaining 111 patients were sequenced one by one starting from the frequently mutated exons until 2 mutant alleles were identified.
###end p 18
###begin title 19
CT scan and thyroid examination
###end title 19
###begin p 20
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 457 465 457 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
###xml 587 595 <span type="species:ncbi:9606">patients</span>
Twenty-nine of 32 individuals who had mutations or variants in SLC26A4 were subjected to temporal bone computerized tomography (CT) scan for the diagnosis of EVA or inner ear malformation based on the criteria of a diameter of greater than 1.5 mm at the midpoint between the common crus and the external aperture[31]. To evaluate for Pendred syndrome, the ultrasound scan of thyroid and the thyroid hormone levels were measured in the patients positive for SLC26A4 mutations or variants. These procedures were performed at the Second Hospital of Chifeng City, Inner Mongolia, China. Ten patients with hyperthyroidism but normal hearing were enrolled as positive control for ultrasound scan of the thyroid and the levels of thyroid hormone. Since perchlorate discharge testing was not a general clinical practice in China, it was not used in this study.
###end p 20
###begin title 21
Results
###end title 21
###begin p 22
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 4 12 <span type="species:ncbi:9606">patients</span>
###xml 103 110 <span type="species:ncbi:9606">Patient</span>
All patients showed severe to profound bilateral sensorineural hearing impairment on audiograms except Patient 9 in Table 1 whose right ear pure tone average (PTA) is 55 dB.
###end p 22
###begin title 23
Correlation of genotype with age of onset of deafness
###end title 23
###begin p 24
###xml 297 305 293 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 390 398 384 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 28 36 <span type="species:ncbi:9606">patients</span>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
###xml 373 381 <span type="species:ncbi:9606">patients</span>
The average age of onset of patients with EVA and/or other inner ear malformation is 1.56 +/- 1.23. The average age of onset of other patients is 0.97 +/- 1.42. There is no significant statistic difference between the two groups (P value 0.09, t = 1.71). The average age of onset of patients with SLC26A4 mutations or variants is 1.27 +/- 1.10. The average age of onset of patients without SLC26A4 mutations or variants is 1.03 +/- 1.24. There is no significant statistic difference between the latter groups (P value 0.46, t = 0.727).
###end p 24
###begin title 25
SLC26A4 mutations
###end title 25
###begin p 26
###xml 21 29 21 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 332 340 332 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1213 1221 1213 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 168 175 <span type="species:ncbi:9606">Patient</span>
###xml 302 310 <span type="species:ncbi:9606">patients</span>
###xml 363 371 <span type="species:ncbi:9606">patients</span>
###xml 559 566 <span type="species:ncbi:9606">Patient</span>
###xml 637 644 <span type="species:ncbi:9606">patient</span>
###xml 655 662 <span type="species:ncbi:9606">Patient</span>
###xml 762 770 <span type="species:ncbi:9606">patients</span>
###xml 784 792 <span type="species:ncbi:9606">patients</span>
###xml 856 864 <span type="species:ncbi:9606">Patients</span>
###xml 1058 1065 <span type="species:ncbi:9606">Patient</span>
###xml 1256 1264 <span type="species:ncbi:9606">patients</span>
Sequence analysis of SLC26A4 in these 111 patients with hearing impairment identified 16 patients (1 to 16) with two confirmed pathogenic mutations (Table 1), and one (Patient 17) with compound heterozygote of two unclassified variants, Y375C and R470H, which are most likely pathogenic (Table 1). Six patients (19 to 24) carry one SLC26A4 mutant allele, and two patients (18 and 25) carry a novel unclassified missense variant, I491T and L597S, respectively, that are likely pathogenic due to their evolutionary conservation and conserved amino acid change. Patient 26 carried V659L, a pathogenic mutation that has also been found in a patient with EVA (Patient 11). The pathogenicity of V659L is reported by Wang et al. in Chinese enlarged vestibular aqueduct patients[27]. Each of patients 27 to 29 is heterozygous for an unclassified missense variant. Patients 27 and 28 carrying a single conserved amino acid change, I235V and T67S respectively, had normal vestibular aqueducts. These two missense variants are probably benign. The novel IVS12-6insT in Patient 29 does not predict a gain or loss of a spice site when analyzed using programe available on . So it is also considered benign. Thus, mutations in SLC26A4 were identified in 19.26% (26/135) patients with hearing impairment in Inner Mongolia, China, 17 with two mutant alleles and 9 with one mutant allele.
###end p 26
###begin p 27
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
Phenotype and genotype of SLC26A4 gene related hearing impairment in Inner mongilia
###end p 27
###begin p 28
Novel mutations are in bold and italic. nl = normal, EVA = enlarged vestibular aqueduct, ND = not determined, NA = not available, CT = computerized tomography, PTA(L) or (R) = pure tone average(left) or (R), IVS7 = intravening sequence 7 (intron 7), IVS12 = intravening sequence 12 (intron 12), Diameter = Diameter at the midpoint between the common crus and the external aperture.
###end p 28
###begin p 29
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 655 663 <span type="species:ncbi:9606">patients</span>
A total of 7 different pathogenic mutations (IVS7-2A>G, E37X, K77I, S391R, N392Y, T410M, H723R) and 5 most likely pathogenic novel variants (Y375C, R470H, I491T, L597S, and H723D) were found. The E37X mutation that results in a premature stop codon and a truncated protein of less than 5% in length is predicted to be deleterious. The H723D mutation is caused by nucleotide substitution, c.2167C>G, which is predicted to be deleterious since a milder change at the same amino acid residue, H723R that has been found to be the most common pathogenic mutation in Japanese. Other missense mutations: K77I, S391R, N392Y, T410M and H723R have been reported in patients with hearing loss in other studies[26,27,29].
###end p 29
###begin p 30
###xml 388 396 388 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 418 419 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 547 554 547 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 32 39 <span type="species:ncbi:9606">patient</span>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
###xml 133 141 <span type="species:ncbi:9606">patients</span>
The most common mutation in our patient cohort is the aberrant splice site alteration, IVS7-2A>G. Eight patients were homozygotes, 4 patients were compound heterozygotes with another mutant allele, and 5 were heterozygotes without a second mutant allele. The IVS7-2A>G mutation accounts for 58.14% (25/43, counting only the definite pathogenic and most likely pathogenic variants) of all SLC26A4 mutant alleles (Table 1). These results suggest that a significant proportion (26/135 = 19.26%) of Chinese hearing impairment has molecular defects in SLC26A4.
###end p 30
###begin title 31
SLC26A4 mutations in control individuals
###end title 31
###begin p 32
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 314 322 314 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 395 403 395 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
In order to determine carrier frequency in general population, SLC26A4 exons 2-21 of 50 normal hearing individuals were analyzed by DHPLC. One IVS7-2A>G heterozygote and one silent variant 2217A>G (Q739Q) were found. Although this control population is too small to reach the final conclusion, the carrier rate of SLC26A4 mutation in northern China is estimated to be about 2%. Polymorphisms in SLC26A4 gene appear to be rare in general population when compared to GJB2 gene.
###end p 32
###begin title 33
SLC26A4 polymorphisms
###end title 33
###begin p 34
Three novel silent variants were identified; c.1905C>G (E635E), c.678T>C (A226A) and c.225C>G (L75L). These silent variants are not detected in the 50 control individuals.
###end p 34
###begin title 35
###xml 53 60 <span type="species:ncbi:9606">patient</span>
Comparison of SLC26A4 mutation spectrum in different patient population
###end title 35
###begin p 36
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 523 531 523 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 731 739 731 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 51 59 <span type="species:ncbi:9606">patients</span>
###xml 659 667 <span type="species:ncbi:9606">patients</span>
In Asian population, more than 80% of nonsyndromic patients with EVA harbored mutations in SLC26A4 [19,27,29,30]. In Taiwan and China, both made up of >90% Han Chinese, the IVS7-2A>G splice mutation is the most prevalent. In Japan, H723R is the most prevalent. In Korea, IVS7-2A>G and H723R are the two most prevalent mutations. There seems to be a shift of mutation from IVS7-2A>G to H723R from China to Japan with Korea in the middle. Each population has its own rare variants that are not shared (Table 2). Mutations in SLC26A4 is very diverse in European and US populations without any prevalent mutations that account for more than 10% of the alleles in patients with Pendred syndrome or EVA (Table 2) [15,23,26]. Variants in SLC26A4 gene in Caucasians are rarely overlapped with those found in Asians.
###end p 36
###begin p 37
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
SLC26A4 mutation spectrum among different populations
###end p 37
###begin p 38
Numbers in the parentheses are the percentages of mutant alleles in total SLC26A4 mutant alleles identified.
###end p 38
###begin p 39
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
a All mutations found in Asian populations are listed, Only the mutations that occurred in at least 3 unrelated families of the European and US populations or the mutations that had occurred in other populations are listed to show the diversity of mutations and the lack of prevalent mutations.
###end p 39
###begin p 40
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
b total number of chromosome studied = number of patients x 2
###end p 40
###begin title 41
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Frequencies of SLC26A4 mutations in nonsyndromic deafness, EVA, and Pendred syndrome patients
###end title 41
###begin p 42
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 184 192 184 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 504 505 504 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 573 581 573 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 788 796 788 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 906 914 906 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 218 225 <span type="species:ncbi:9606">Patient</span>
###xml 227 234 <span type="species:ncbi:9606">patient</span>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
###xml 633 641 <span type="species:ncbi:9606">patients</span>
###xml 697 705 <span type="species:ncbi:9606">patients</span>
###xml 835 843 <span type="species:ncbi:9606">patients</span>
###xml 955 963 <span type="species:ncbi:9606">patients</span>
###xml 1001 1009 <span type="species:ncbi:9606">patients</span>
CT scan was performed on 29 of the 32 patients listed in Table 1. Among them, 20 (69%) had EVA and/or Mondini dysplasia. Seventeen patients (17/20 = 85%) who harbored two mutations in SLC26A4 gene. had EVA, except one Patient (patient 17, Y375C and R470H) had vestibular and cochlea malformation. Only 3 out of the 7 patients who carry one heterozygous mutation had EVA, the other 4 were normal. All patients who were heterozygous for silent and most likely benign variants were normal on CT scan (Table 1). Since CT scan was performed after genotyping, only patients with SLC26A4 mutations or variants received CT scan. 100% of our patients with two mutant alleles (17/17) and only 33.3%(3/9) of patients with one mutant allele were confirmed to have EVA manifestation. The frequency of SLC26A4 mutations in our nonsyndromic deafness patients is 19.3% (26/135). Most reported studies focused on screening SLC26A4 mutations in the EVA or Pendred syndrome patients but not in the nonsyndromic deafness patients.
###end p 42
###begin p 43
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 346 354 346 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 500 508 500 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
###xml 406 414 <span type="species:ncbi:9606">patients</span>
###xml 421 429 <span type="species:ncbi:9606">Patients</span>
Other Asian studies report high frequency of finding SLC26A4 mutations in patients with EVA, 97.9, 87, 92, and 68% respectively for mainland China, Taiwanese, Korean and Japanese [8,27,29,32,33]. The mutation detection rate in Caucasian EVA patients is much lower, 53 and 40% respectively in UK and Europe [26,34]. In US population, mutations in SLC26A4 account for about one third of the nonsyndromic EVA patients [15]. Patients with Pendred syndrome, however, had higher mutation detection rate in SLC26A4 gene, 90% in a French study [23].
###end p 43
###begin title 44
CT scan
###end title 44
###begin p 45
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 81 89 <span type="species:ncbi:9606">patients</span>
###xml 255 262 <span type="species:ncbi:9606">Patient</span>
###xml 397 404 <span type="species:ncbi:9606">Patient</span>
###xml 592 600 <span type="species:ncbi:9606">patients</span>
###xml 662 670 <span type="species:ncbi:9606">Patients</span>
###xml 773 781 <span type="species:ncbi:9606">patients</span>
###xml 900 908 <span type="species:ncbi:9606">patients</span>
CT scan revealed EVA and/or other inner ear malformation in 20 patients. Sixteen patients (1 to16) had EVA and two pathogenic mutant alleles, consistent with autosomal recessive disorder caused by bi-allelic loss of function of pendrin protein (Table 1). Patient 17 had common cystic cavity of cochlea and vestibule without EVA. She carried two novel missense variants Y375C and R470H (Figure 1). Patient 18 had enlarged vestibular aqueduct with Mondini dysplasia (Figure 1). He carried a novel I491T variant. These results suggest that Y375C, R470H and I491T are most likely pathogenic. Two patients with one mutant IVS7-2A>G allele had EVA. CT scan results of Patients 21 and 22 (heterozygote IVS7-2A>G and N392Y respectively) were not available (Table 1). The remaining patients had normal CT scan. Testing of the 3 most frequent mutations, IVS7-2 A>G, H723R and T410M, can lead to finding 80% of patients with EVA or inner ear malformation in this cohort
###end p 45
###begin p 46
###xml 0 2 0 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 126 128 126 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B </bold>
###xml 20 27 <span type="species:ncbi:9606">Patient</span>
###xml 141 148 <span type="species:ncbi:9606">Patient</span>
A 1124A>G/1409G>A. (Patient 17). The black arrows in the CT picture showed the common cystic cavity of cochlea and vestibule. B 1472T>C/wt. (Patient 18). The white arrows in the CT picture showed the hypolastic cochlea (Mondini). The black arrows in the CT picture showed EVA.
###end p 46
###begin p 47
###xml 378 386 378 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 8 16 <span type="species:ncbi:9606">patients</span>
###xml 165 172 <span type="species:ncbi:9606">patient</span>
###xml 233 240 <span type="species:ncbi:9606">Patient</span>
Several patients have multiple affected siblings with the same two mutant alleles supporting that EVA is an autosomal recessive disease. For example, two sisters of patient 9 with the same genotype (IVS7-2A>G/K77I) and one sister of Patient 6 with homozygous IVS7-2A>G all have EVA. The parents of these two families are normal hearing individuals and carriers of corresponding SLC26A4 mutations.
###end p 47
###begin title 48
Thyroid ultrasound and thyroid hormone assays
###end title 48
###begin p 49
###xml 103 111 103 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
###xml 164 171 <span type="species:ncbi:9606">patient</span>
###xml 173 180 <span type="species:ncbi:9606">Patient</span>
###xml 384 392 <span type="species:ncbi:9606">patients</span>
###xml 394 401 <span type="species:ncbi:9606">Patient</span>
###xml 408 415 <span type="species:ncbi:9606">Patient</span>
Thyroid ultrasound was performed to determine presence or absence of goitre. None of the patients with SLC26A4 mutations or variants was diagnosed goitre. Only one patient (Patient 13) with EVA was found cystoid change in the thyroid by ultrasound scan, while there was no change in the thyroid hormone levels. Thyroid hormone assays showed that total T3 was slightly elevated in two patients (Patient 3 and Patient 19), but this abnormity had no clinical value when evaluated by endocrinologist from Chinese PLA General Hospital.
###end p 49
###begin title 50
Discussion
###end title 50
###begin p 51
###xml 309 317 309 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 495 503 <span type="species:ncbi:9606">patients</span>
###xml 921 929 <span type="species:ncbi:9606">patients</span>
###xml 1016 1024 <span type="species:ncbi:9606">patients</span>
Diagnosis of Pendred syndrome EVA requires the evaluation of inner ear malformation by temporal bone CT scan. Unfortunately, in Chifeng City, Inner Mongolia, China, the temporal bone CT scan was too expensive to perform and there was lack of expertise for temporal bone evaluation. Under these circumstances, SLC26A4 mutation analysis may be the only alternative way for the diagnosis of EVA, since blood samples can be collected locally and sent elsewhere for DNA analysis. In this study, 100% patients (17/17) with bi-allelic mutation were confirmed to have EVA by CT scan performed in Chifeng Second Hospital with the help of a specialist from Beijing. Perchlorate discharge testing, a routine testing for thyroid function, is not available in most area of China. We use thyroid hormone testing and ultrasound scan of thyroid to examine the function and structure of thyroid instead. Our results indicate that none of patients have PS. These may be explained by a). testing methods were different, b). the age of patients undertaking thyroid ultrasound and thyroid hormone assays, 3 to 20, average 13.24 +/- 3.92, in this study may be too young to have symptoms, c). phenotypic diversity due to different genetic background.
###end p 51
###begin p 52
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
In this study, we found that SLC26A4 mutations were detected in nearly 20% of our patients with hearing impairment with IVS7-2A>G being the most prevalent mutation. Among the novel variants, Y375C, R470H, I491T, L597S and H723D were considered pathogenic based on a) they are located in evolutionarily conserved regions (Figure 2), b) substituted amino acids are structurally and functionally different from amino acids of the wild type, c) Y375C, R470H, I491T, L597S and H723D have been found in patients with EVA or other forms of inner ear malformation, and d) they were not present in our normal controls.
###end p 52
###begin p 53
An alignment will display by default the following symbols denoting the degree of conservation observed in each column: "*" means that the residues or nucleotides in that column are identical in all sequences in the alignment. ":" means that conserved substitutions have been observed, "." means that semi-conserved substitutions are observed. The black arrows shows the amino acid related to newly found mutations or variants.
###end p 53
###begin p 54
###xml 533 541 533 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 611 619 611 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 30 37 <span type="species:ncbi:9606">patient</span>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
###xml 667 675 <span type="species:ncbi:9606">patients</span>
###xml 840 848 <span type="species:ncbi:9606">patients</span>
It's interesting to note that patient 18 with inner ear malformation carry one missense mutation only, whether the missense mutation causes dominant negative effect and/or specifies a different phenotype is not clear. Three patients (18 to 20) with EVA or other inner ear malformation harbored only one mutant allele. It's possible that the second mutant allele has not yet been identified due to a) mutations deep in introns or promoter regions that are not sequenced, b) intragenic exon deletions, c) mutations in genes other than SLC26A4 may involve in the pathogenesis (digenic). Thus, the mutations in the SLC26A4 gene account for at least 12.6% (17/135) of the patients with nonsyndromic hearing loss, making it as equally commonly mutated gene as GJB2 (23/135 no significant difference found after statistical analysis, P > 0.05) in patients from Inner Mongolia.
###end p 54
###begin p 55
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 187 195 187 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 274 282 274 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 438 446 438 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 504 512 504 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 862 869 862 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4</italic>
###xml 758 762 <span type="species:ncbi:10090">mice</span>
Unlike GJB2 which is a small gene with a lot of missence variants, SLC26A4 is a relatively large gene with rare missense benign polymorphisms or variants. Thus, novel missense variant in SLC26A4 is possibly pathogenic. Two questions were raised: can the autosomal recessive SLC26A4 mutations cause hearing impairment without EVA or other inner ear malformation, and are there other genes involved in the pathogenesis of hearing loss with SLC26A4 (digenic). To answer the first question, screening of the SLC26A4 mutations in a large NSHI population without EVA is necessary. For the second question, Malin Hulander reported that the lack of pendrin expression led to deafness and expansion of the endolymphatic compartment in inner ears of Foxi1 null mutant mice [34]. His observation provides the direct evidence that other genes may modulate the expression of SLC26A4. Alternatively there may be dominant negative effect.
###end p 55
###begin p 56
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 681 689 681 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 744 749 744 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 821 826 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 994 999 994 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1002 1010 1002 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 1097 1102 1097 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GJB2 </italic>
###xml 1106 1114 1106 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 1192 1194 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1234 1242 1234 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 529 537 <span type="species:ncbi:9606">patients</span>
###xml 664 672 <span type="species:ncbi:9606">patients</span>
###xml 770 778 <span type="species:ncbi:9606">patients</span>
###xml 866 874 <span type="species:ncbi:9606">patients</span>
###xml 938 946 <span type="species:ncbi:9606">patients</span>
###xml 1057 1065 <span type="species:ncbi:9606">patients</span>
###xml 1177 1184 <span type="species:ncbi:9606">patient</span>
###xml 1279 1287 <span type="species:ncbi:9606">patients</span>
###xml 1310 1318 <span type="species:ncbi:9606">patients</span>
The SLC26A4 mutation spectrum in ChiFeng City, Inner Mongolia is similar to that reported in Chinese population but different from that of Japanese. There is a gradient shift of the most prevalent mutation from IVS7-2A>G to H723R, respectively, from Chinese to Japanese with both mutations being equally prevalent in Korean. This observation suggests that IVS7-2A>G and H723R mutations may be the ancient mutations in China and Japan respectively. The unique rare mutations evolved more recently. A recent study of 100 unrelated patients with EVA in European Caucasians by Albert et al. revealed a diverse mutation spectrum without prevalent mutations and only 40 patients carried SLC26A4 mutations[26]. Our previous study on the prevalence of GJB2 mutations in Chinese patients with hearing impairment demonstrated that GJB2 mutations were detected in 30.4% of the patients in ChiFeng city. Together, approximately 49.63% (41+26/135) of patients with NSHI in ChiFeng city carried mutations in GJB2 or SLC26A4 gene. Whereas about 33.1% and 3.5% of European patients with NSHI carried mutations in GJB2 and SLC26A4 respectively, with a total of 36.6%, comparable to that in our patient group [35]. It is not clear why the mutations in SLC26A4 account for much lower percentage of patients with EVA in Caucasian patients. Presumably, other genetic factors and environmental factors are involved in the pathogenesis of EVA in Caucasians.
###end p 56
###begin p 57
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 414 422 414 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 437 445 437 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 133 141 <span type="species:ncbi:9606">patients</span>
###xml 314 321 <span type="species:ncbi:9606">patient</span>
###xml 399 407 <span type="species:ncbi:9606">patients</span>
###xml 470 478 <span type="species:ncbi:9606">patients</span>
The striking spot of this study is that a new strategy that detects SLC26A4 mutations prior to the temporal bone CT scan to find EVA patients are established. In China, the cost of temporal CT scan is 200 to 300 RMB, because of the relatively high cost, it is not possible to perform CT scan in every hearing loss patient in molecular epidemiologic study to diagnose EVA. Since 97.9% of Chinese EVA patients carry SLC26A4 mutation [27], SLC26A4 mutation in hearing loss patients indicates a high possibility of EVA. This model presents unique advantage in epidemiologic study in large-scale deaf population to find EVA.
###end p 57
###begin title 58
Conclusion
###end title 58
###begin p 59
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 251 259 251 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC26A4 </italic>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
In Inner Mongolia, China, mutations in SLC26A4 gene account for at least 12.6% (17/135) of the patients with nonsyndromic hearing loss. Pendred syndrome is not detected in the Inner Mongolia deaf population. We established a new strategy that detects SLC26A4 mutations prior to the temporal bone CT scan to find EVA and inner ear malformation patients. This model has a unique advantage in epidemiologic study of large deaf population.
###end p 59
###begin title 60
Competing interests
###end title 60
###begin p 61
The authors declare that they have no competing interests.
###end p 61
###begin title 62
Authors' contributions
###end title 62
###begin p 63
Pu Dai, Yongyi Yuan and Deliang Huang carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. Xiuhui Zhu carried out temporal CT scan and thyroid hormone assays. Dongyang Kang participated in the sequence alignment. Fei Yu and Huijun Yuan participated in the design of the study and performed the statistical analysis. Dongyi Han and Bailin Wu conceived of the study, and participated in its design and coordination and helped to draft the manuscript. Lee-Jun Wong reviewed and interpreted the results, drafted and revised the manuscript. All authors read and approved the final manuscript.
###end p 63
###begin title 64
Acknowledgements
###end title 64
###begin p 65
This work was supported by Chinese National Nature Science Foundation Research Grant (30572015, 30872862), Beijing Nature Science Foundation Research Grant (7062062) to Dr. Pu Dai and Chinese National Nature Science Foundation Research Grant (30801285) to Dr. Yongyi Yuan.
###end p 65
###begin article-title 66
A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment
###end article-title 66
###begin article-title 67
###xml 36 42 <span type="species:ncbi:9606">Infant</span>
Personal Health; Early Detection of Infant Deafness Is Vital
###end article-title 67
###begin article-title 68
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Molecular etiology of patients with nonsyndromic hearing loss from deaf-muta schools in 18 provinces of China
###end article-title 68
###begin article-title 69
Epidemiology, etiology and genetic patterns
###end article-title 69
###begin article-title 70
Connexin-26 mutations in sporadic and inherited sensorineural deafness
###end article-title 70
###begin article-title 71
Connexin-26 mutations in sporadic non-syndromal sensorineural deafness
###end article-title 71
###begin article-title 72
Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness
###end article-title 72
###begin article-title 73
Connexin26 mutations associated with nonsyndromic hearing loss
###end article-title 73
###begin article-title 74
Molecularbasis of childhood deafness resulting from mutations in the GJB2 (connexin 26) gene
###end article-title 74
###begin article-title 75
High frequency hearing loss correlated with mutations in the GJB2 gene
###end article-title 75
###begin article-title 76
Mutations in the connexin26/GJB2 gene are the most common event in nonsyndromic hearing loss among the German population
###end article-title 76
###begin article-title 77
GJB2 deafness gene shows a specific spectrum of mutations in Japan, including a frequent founder mutation
###end article-title 77
###begin article-title 78
The prevalence of the 235delC GJB2 mutation in a Chinese deaf population
###end article-title 78
###begin article-title 79
Pendred syndrome - 100 years of underascertainment?
###end article-title 79
###begin article-title 80
SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and nonsyndromic EVA are distinct clinical and genetic entities
###end article-title 80
###begin article-title 81
Radiological malformations of the ear in Pendred syndrome
###end article-title 81
###begin article-title 82
The large vestibular aqueduct syndrome
###end article-title 82
###begin article-title 83
Progressive hearing loss, hypoplasia of the cochlea and widened vestibular aqueducts are very common features in Pendred's syndrome
###end article-title 83
###begin article-title 84
Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness
###end article-title 84
###begin article-title 85
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Expression pattern of the mouse ortholog of the Pendred's syndrome gene (Pds) suggests a key role for pendrin in the inner ear
###end article-title 85
###begin article-title 86
Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells
###end article-title 86
###begin article-title 87
Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations
###end article-title 87
###begin article-title 88
Screening of SLC26A4 (PDS) gene in Pendred's syndrome: a large spectrum of mutations in France and phenotypic heterogeneity
###end article-title 88
###begin article-title 89
Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans
###end article-title 89
###begin article-title 90
Pendred syndrome and DFNB4-mutation screening of SLC26A4 by denaturing high-performance liquid chromatography and the identification of eleven novel mutations
###end article-title 90
###begin article-title 91
SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations
###end article-title 91
###begin article-title 92
###xml 44 52 <span type="species:ncbi:9606">patients</span>
A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China
###end article-title 92
###begin article-title 93
Identification of five new mutations of PDS/SLC26A4 in Mediterranean families with hearing impairment
###end article-title 93
###begin article-title 94
Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese
###end article-title 94
###begin article-title 95
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Prevalent SLC26A4 mutations in patients with enlarged vestibular aqueduct and/or Mondini dysplasia: a unique spectrum of mutations in Taiwan, including a frequent founder mutation
###end article-title 95
###begin article-title 96
Largevestibular aqueduct syndrome and congenital sensorineural hearing loss
###end article-title 96
###begin article-title 97
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Mutation spectrum of the connexin 26 (GJB2) gene in Taiwanese patients with prelingual deafness
###end article-title 97
###begin article-title 98
GJB2 gene mutations in newborns with non-syndromic hearing impairment in Northern China
###end article-title 98
###begin article-title 99
###xml 127 131 <span type="species:ncbi:10090">mice</span>
Lack of pendrin expression leads to deafness and expansion of the endolymphatic compartment in inner ears of Foxi1 null mutant mice
###end article-title 99
###begin article-title 100
Assessment of the genetic causes of recessive childhood nonsyndromic deafness in the UK - implications for genetic testing
###end article-title 100

